Abstract:Objective: To identify the factors associated with long-term survival and guide the decision for primary surgery in patients with advanced high-grade serous ovarian cancer(HGSOC). Methods: In this case-control study, clinical parameters, including surgical and non-surgical associated factors, were collected and compared between the patients with short-term (<2 years) and long-term (>5 years) survival who all underwent primary debulking surgery (PDS) followed by carboplatin and paclitaxel chemotherapy from January 2004 to December 2016. Univariate analysis was examined by chi-square test and multivariate analysis was performed by logistic regression analysis. Results: There were 95 cases long-term survival (LTS group) and 77 cases short-term survival (STS group) in 698 newly diagnosed HGSOC patients with International Federation of Gynecology and Obstetrics (FIGO) stage Ⅲc and Ⅳ who met include and exclude criteria. (1) Univariate analysis showed that the proportion of complete cytoreduction with no visible residual disease (R0) at PDS and platinum sensitivity in LTS group were significantly higher than those in STS group (P<0.01). The surgical complexity score (SCS), the preoperative serum CA125 level and the ascites volume in the LTS group were significantly lower than those of the STS group (all P<0.05). In the LTS group, the preoperative incidence of lesions in retrograde peritoneum of the bladder, serosal and mesangial membrane of the small intestine, upper abdominal peritoneum and liver parenchyma were significantly lower than those in the STS group (all P<0.05). Multivariate logistic regression analysis showed that platinum sensitivity (OR=0.016, 95%CI: 0.004-0.063, P<0.01), ascites volume >500 ml (OR=3.193, 95%CI: 1.285-7.930, P=0.012), and SCS ≥8 (OR=17.433, 95%CI: 2.281-133.25, P=0.003) were independent factors affecting long-term survival (P>0.05). (2) Totally 37 of 95 in long-term survival and 16 of 77 in short-term survival achieved R0 cytoreduction at PDS. Univariate analysis showed that preoperative serum CA125 level, preoperative lesion score, preoperative lesion (DS) score, ascites volume, platinum sensitivity,and SCS were significantly correlated with the R0 PDS (all P<0.05). Multivariate analysis showed that ascites volume >500 ml (OR=5.199, 95%CI: 2.015-13.409, P=0.001), DS >2 (OR=15.264, 95%CI: 5.843-39.874, P<0.01) and SCS ≥4 (OR=4.176, 95%CI: 1.618-10.777, P=0.003) were independent factors associated with R0 cytoreduction. In patients with DS ≤2 or SCS <4, but not those with DS >2 or SCS ≥4, R0 cytoreduction was significantly associated with long-term survival. Conclusion: The intrinsic biology of tumor is the factor influencing long-term survival of advanced HGSOC patients, and those who present with wide intraperitoneal metastases and need to remove multiple organs may not benefit from R0 cytoreduction.

Identification of Prognostic Factors for Krukenberg Tumor

A Retrospective Study of Clinicopathological Characteristics and Prognostic Factors of Krukenberg Tumor with Gastric Origin

A Comparative Study of RTK Gene Status Between Primary Tumors, Lymph-Node Metastases, and Krukenberg Tumors

Clinicopathological Characteristics and Prognostic Factors of 130 Patients with Krukenberg Tumors of Gastric Origin.

Surgical Treatment for Patients with Krukenberg Tumor of Stomach Origin: Clinical Outcome and Prognostic Factors Analysis.

Clinical Characteristics and Prognostic Analysis of Krukenberg Tumor

Surgical Treatment for Patients with Different Origins of Krukenberg Tumors: Outcomes and Prognostic Factors

Metastasectomy of Krukenberg Tumors May Be Associated with Survival Benefits in Patients with Metastatic Gastric Cancer.

Clinicopathological features and clinical outcomes in individuals with Krukenberg tumors of colorectal origin.

Clinical Characters and Survival Analysis of Twenty-Seven Cases with Krukenberg Tumors

PD-L1 Expression Predicts a Distinct Prognosis in Krukenberg Tumor with Corresponding Origins

Clinical Outcomes in Patients With Krukenberg Tumors From Colorectal Cancer

Diagnosis and Treatment of Krukenberg Tumors: Analysis of 24 Cases

Effects of metastasectomy and other factors on survival of patients with ovarian metastases from gastric cancer: a systematic review and meta-analysis

Analysis of prognosis factors and follow-up strategy of ovary metastasis derived from gastric and colorectal cancer

Analyzing Clinical and Pathological Features of 36 Cases Krukenberg Tumor

Comprehensive analysis of factors that involve in survival and prognosis in patients with gastrointestinal stromal tumors

What Influences the Long-Term Survival of Advanced High-Grade Serous Ovarian Cancer?

Primary ovarian Tnmors and Krukenberg Tumors:COnfusing Areas of Diagnosis

Clinical Characteristics and Outcomes of Gastrointestinal Stromal Tumor Patients Receiving Surgery with or Without TKI Therapy: a Retrospective Real-World Study

SKP2 High Expression, KIT Exon 11 Deletions, and Gastrointestinal Bleeding As Predictors of Poor Prognosis in Primary Gastrointestinal Stromal Tumors.